Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Julien Hadoux, Christina Kanaan, Alice Durand, et al.
Pediatric Blood & Cancer
|
March 16, 2026
European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents
Michaela Kuhlen, Calogero Virgone, Antje Redlich, et al.
The New England Journal of Medicine
|
October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid Cancer
Julien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 27, 2023
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study
Vivek Subbiah, Mimi I Hu, Aaron S Mansfield, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network
Arnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 30, 2021
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First Appraisal
Sophie Moog, Frédéric Castinetti, Christine DoCao, et al.
Nature Cancer
|
February 5, 2022
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort
Laurence Albiges, Stéphanie Foulon, Arnaud Bayle, et al.
The Lancet. Oncology
|
June 1, 2026
[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial
Eric Baudin, Alice Durand, Amandine Beron, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 31, 2019
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma
Alexandre Buffet, Laurène Ben Aim, Sophie Leboulleux, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 14, 2026
Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas
Rossella Libé, Matthieu Faron, Anne-Sophie Foucan, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Julien Hadoux, Christina Kanaan, Alice Durand, et al.
Pediatric Blood & Cancer
|
March 16, 2026
European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents
Michaela Kuhlen, Calogero Virgone, Antje Redlich, et al.
The New England Journal of Medicine
|
October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid Cancer
Julien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 27, 2023
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study
Vivek Subbiah, Mimi I Hu, Aaron S Mansfield, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network
Arnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 30, 2021
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First Appraisal
Sophie Moog, Frédéric Castinetti, Christine DoCao, et al.
Nature Cancer
|
February 5, 2022
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort
Laurence Albiges, Stéphanie Foulon, Arnaud Bayle, et al.
The Lancet. Oncology
|
June 1, 2026
[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial
Eric Baudin, Alice Durand, Amandine Beron, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 31, 2019
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma
Alexandre Buffet, Laurène Ben Aim, Sophie Leboulleux, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 14, 2026
Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas
Rossella Libé, Matthieu Faron, Anne-Sophie Foucan, et al.
Page
of 12